Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.36 - $1.78 $4,392 - $21,716
-12,200 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$0.51 - $1.0 $306 - $600
-600 Reduced 4.69%
12,200 $1,000
Q4 2021

Feb 14, 2022

BUY
$0.91 - $4.16 $11,648 - $53,248
12,800 New
12,800 $1,000
Q2 2021

Aug 11, 2021

SELL
$4.1 - $5.33 $62,319 - $81,016
-15,200 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$4.93 - $7.15 $74,936 - $108,680
15,200 New
15,200 $4,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.